Shree Ganesh Remedies (SGRL) Share Price Falls 8.35%: What SGRL Share Price Shows Today

Shree Ganesh Remedies Share Price is under pressure today after SGRL traded at Rs 634, down 8.35% from the previous close of Rs 691.75, with market capitalisation at Rs 888.04 crore. According to Univest data, the price event is confirmed, but no company-specific catalyst is established. The move places Shree Ganesh Remedies Share Price in focus for investors tracking Healthcare names and micro cap valuation. As of 21 October 2026 at 1:22:48 PM IST, the stock is trading below its opening level and within the lower part of its day range. In Shree Ganesh Remedies Stock News, the verified numbers matter more than speculation: the share price fall is visible, the valuation remains elevated versus many sector benchmarks, and the business is being assessed through its reported earnings, book value and returns. The latest Univest figures also show that today’s move is a fresh intraday decline rather than a multi-session stretch.

Shree Ganesh Remedies (SGRL) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 634
Previous Close	Rs 691.75
Today's Move	-Rs 57.75 (-8.35%)
Open	Rs 684.65
High	Rs 684.65
Low	Rs 624.85
Market Capitalisation	Rs 888.04 crore
Market Cap Category	Micro Cap

Shree Ganesh Remedies Share Price today reflects a clear intraday fall. SGRL last traded at Rs 634, compared with the previous close of Rs 691.75, which leaves a decline of Rs 57.75 or 8.35%. The stock opened at Rs 684.65, touched a high of Rs 684.65 and a low of Rs 624.85 during the ongoing session. That range shows that Shree Ganesh Remedies Share Price moved lower after the open and has stayed beneath the opening level through the latest update.

The company’s market capitalisation stands at Rs 888.04 crore, which places it in the Micro Cap category. For readers following Shree Ganesh Remedies Share Price Today, the important point is not only the percentage decline but also the position of the share price versus the day’s open and the previous close. Shree Ganesh Remedies Share Price is now closer to the lower end of the session range than to the day high, which keeps the latest price action in sharp focus for anyone scanning SGRL Share Price Live updates. That setup leads naturally into the fundamental picture behind the stock.

Shree Ganesh Remedies (SGRL) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 888.04 crore
P/E Ratio	57.53x
P/B Ratio	5.41x
ROE	11.53%
ROCE	14.63%
EPS	Rs 12.02
Book Value Per Share	Rs 127.82
Dividend Yield	0%

Shree Ganesh Remedies (SGRL) fundamental metrics show P/E 57.53x, P/B 5.41x, ROE 11.53%, ROCE 14.63%. These figures provide context only and are not a buy or sell signal.

Shree Ganesh Remedies has a market capitalisation of Rs 888.04 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 57.53x, P/B at 5.41x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 11.53% and ROCE of 14.63%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 12.02, book value per share of Rs 127.82, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.73x, median ROE of 11.33%, median ROCE of 13.25%. Taken together, they outline the fundamentals rather than a view on the stock.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	57.53x
Benchmark Median P/E	31.73x
Benchmark Average P/E	45.98x
Benchmark P/E Range	3.1x to 616.89x
Company P/B Ratio	5.41x
Benchmark Median P/B	2.76x
Benchmark Average P/B	4.11x
Company ROE	11.53%
Benchmark Median ROE	11.33%
Benchmark Average ROE	10.14%
Company ROCE	14.63%
Benchmark Median ROCE	13.25%
Benchmark Average ROCE	13.05%
Company Market Capitalisation	Rs 888.04 crore
Benchmark Median Market Cap	Rs 771.43 crore
Benchmark Average Market Cap	Rs 13,467.03 crore

Shree Ganesh Remedies (SGRL) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

Shree Ganesh Remedies (SGRL) has a P/E ratio of 57.53x, which is above the benchmark median of 31.73x, a difference of +81.31%. On its own, the P/E gap is a valuation reference point, not a trading call.

Shree Ganesh Remedies (SGRL) has a ROE of 11.53%, which is above the benchmark median of 11.33%, a difference of +1.77%. Shree Ganesh Remedies (SGRL) has a ROCE of 14.63%, which is above the benchmark median of 13.25%, a difference of +10.42%.

Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries	SUNPHARMA	4,18,683.95	34.61	4.84	14.85	19.11
Divi's Laboratories	DIVISLAB	2,41,310.94	82.5	13.66	16.19	21.51
Torrent Pharmaceuticals	TORNTPHARM	1,73,078.79	79.36	19.28	26.76	19.27
Laurus Labs	LAURUSLABS	1,11,433.99	101.92	19.76	18.31	18.2
Zydus Lifesciences	ZYDUSLIFE	1,11,022.18	24.6	4.12	19.69	21.39

Shree Ganesh Remedies (SGRL) has a P/E ratio of 57.53x compared with the displayed peer median of 79.36x. This peer read is a relative benchmark rather than a trading signal. Its ROE of 11.53% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 14.63% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Shree Ganesh Remedies (SGRL) has a market capitalisation of Rs 888.04 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Shree Ganesh Remedies

• Shree Ganesh Remedies Share Price fell 8.35% to Rs 634, making the latest intraday move the first thing investors notice.
• The stock trades in the Micro Cap category, so Shree Ganesh Remedies Share Price can move sharply even on a single session.
• P/E of 57.53 and P/B of 5.41 keep valuation central to Shree Ganesh Remedies Fundamental Analysis.
• ROE of 11.53% and ROCE of 14.63% give a real earnings context for Shree Ganesh Remedies Share Price.
• In Healthcare and Pharmaceuticals & Drugs, the stock sits above the industry median on valuation, which keeps SGRL Share Price in focus.

About Shree Ganesh Remedies

Shree Ganesh Remedies operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company is tracked by Univest as a listed micro cap with a market capitalisation of Rs 888.04 crore. Shree Ganesh Remedies Share Price is therefore followed not just for daily movement but also for what its valuation and returns signal inside a competitive pharma segment. The business context available here places the company within a large industry benchmark set, where valuations, profitability and capital returns are compared against much larger peers. For readers looking at SGRL Share Price, the company sits in a sector where earnings quality and pricing discipline matter more than broad market sentiment.

Track Shree Ganesh Remedies Share Price on Univest

Use Shree Ganesh Remedies (SGRL) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.

Track Shree Ganesh Remedies Share Price on Univest for live price updates, fundamental ratios, market capitalisation, 52-week levels and stock insights in one place. Univest also helps users follow Shree Ganesh Remedies Stock News, valuation metrics, sector context and company-level fundamentals without searching across multiple pages. If you want Shree Ganesh Remedies Share Price Today, Univest keeps the latest view organised and easy to monitor.

Frequently Asked Questions

Why is Shree Ganesh Remedies Share Price falling today?

Ans. Shree Ganesh Remedies Share Price is down 8.35% today and last traded at Rs 634. According to Univest data, the price event is confirmed, but no company-specific catalyst is established.

What is the current Shree Ganesh Remedies Share Price?

Ans. Shree Ganesh Remedies Share Price is Rs 634 as of 21 October 2026 at 1:22:48 PM IST. It is lower than the previous close of Rs 691.75 and remains within the session range.

How much did SGRL fall today?

Ans. SGRL fell Rs 57.75, which equals 8.35%. The stock opened at Rs 684.65, touched a high of Rs 684.65 and a low of Rs 624.85 before the latest update. The previous close was Rs 691.75.

What is the market capitalisation of Shree Ganesh Remedies?

Ans. Shree Ganesh Remedies has a market capitalisation of Rs 888.04 crore. That places it in the Micro Cap category and above the same-industry median market cap of Rs 771.43 crore.

How is Shree Ganesh Remedies valued versus its sector?

Ans. Shree Ganesh Remedies Share Price trades at a P/E of 57.53 and P/B of 5.41. Both are above the same-industry median and average, so the valuation sits above the benchmark centre.

What do ROE and ROCE show for SGRL?

Ans. SGRL reports ROE of 11.53% and ROCE of 14.63%. Both are above the same-industry median and average, which gives the stock a reasonable return profile inside its Healthcare peer set.

What do EPS and book value mean for Shree Ganesh Remedies Share Price?

Ans. EPS is Rs 12.02 and book value is 127.82. EPS reflects earnings per share, while book value shows accounting net worth per share, both of which are useful in Shree Ganesh Remedies Share Price analysis.

Does Shree Ganesh Remedies pay a dividend?

Ans. The dividend yield is 0. For Shree Ganesh Remedies Share Price, that means no historical payout yield is reflected in the current figures, so valuation rests more on earnings and returns.

How does Shree Ganesh Remedies compare with peers?

Ans. Compared with peers like Sun Pharmaceutical Industries, Divi's Laboratories and Torrent Pharmaceuticals, Shree Ganesh Remedies Share Price sits at a lower market cap and a mixed valuation-return profile. Its P/E is above some peers and below others.